MARC details
000 -LEADER |
fixed length control field |
03589cam a2200481 a 4500 |
001 - CONTROL NUMBER |
control field |
7012 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
BD-DhEWU |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20190506020002.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110304s2012 stka g b 001 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780702042935 |
|
International Standard Book Number |
9780702042942 (international) |
|
International Standard Book Number |
0702042943 |
|
International Standard Book Number |
0702042935 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)706780869 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DNLM/DLC |
Transcribing agency |
DLC |
Modifying agency |
DLC |
-- |
BD-DhEWU |
Language of cataloging |
eng |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RM262 |
Item number |
.C5 2012 |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WB 330 |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.58 |
Item number |
CLI 2012 |
Edition number |
22 |
245 00 - TITLE STATEMENT |
Title |
Clinical pharmacy and therapeutics / |
Statement of responsibility, etc |
edited by Roger Walker and Cate Whittlesea. |
250 ## - EDITION STATEMENT |
Edition statement |
5th ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Edinburgh : |
Name of publisher, distributor, etc |
Churchill Livingston/Elsevier, |
Date of publication, distribution, etc |
c2012. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xiii, 983 p. : |
Other physical details |
ill. (some col.) ; |
Dimensions |
28 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
Section 1: General Clinical pharmacy process. Prescribing. Practical pharmacokinetics. Drug interactions. Adverse drug reactions. Laboratory data. Parenteral nutrition. Pharmacoeconomics. Section 2: Life stages Neonates. Paediatrics. Geriatrics. Section 3: Therapeutics Gastrointestinal disorders: Peptic ulcer disease. Inflammatory bowel disease. Constipation and diarrhoea. Hepatic disorders:Adverse effects of drugs on the liver. Liver disease. Renal disorders: Acute kidney injury. Chronic kidney disease and end-stage renal failure. Chronic kidney disease and end stage renal failure. Cardiovascular disorders: Hypertension. Coronary heart disease. Chronic heart failure. Arrhythmias. Thrombosis. Dyslipidaemia. Respiratory disorders: Asthma. Chronic obstructive pulmonary disease. Neurological and psychological disorders: Insomnia. Anxiety disorders. Affective disorders. Schizophrenia. Epilepsy. Parkinson's disease. Pain. Nausea and vomiting. Infections: Respiratory infections. Urinary tract infections. Gastrointestinal infections. Infective meningitis. Surgical site infection and antimicrobial prophylaxis. Tuberculosis. HIV infection. Fungal infections. Endocrine disorders: Thyroid and parathyroid disorders. Diabetes mellitus. Obstetric and gynaecological disorders: Menstrual cycle disorders. Menopause. Drugs in pregnancy and lactation. Urological disorders: Prostate disease. Haemotopoietic disorders: Anaemia. Malignant disorders: Leukaemia. Lymphomas. Solid tumours. Rheumatic disorders: Rheumatoid arthritis and osteoarthritis. Gout and hyperuricaemia. Eye disorders: Glaucoma. Skin disorders: Drug-induced skin disorders. Eczema and psoriasis. Wounds. Section 4: Appendices. Medical abbreviations. Glossary. Index |
Title |
TOC |
520 ## - SUMMARY, ETC. |
Summary, etc |
Draws on the skills of pharmacists and clinicians to present optimal drug regimens. This title integrates an understanding of the disease processes with an appreciation of pathophysiological processes, clinical pharmacy and the evidence base. It places emphasis on understanding both the prescribing process and the clinical pharmacy process. |
526 ## - STUDY PROGRAM INFORMATION NOTE |
Program name |
Pharmacy |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Abdul Gani |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Chemotherapy. |
9 (RLIN) |
9271 |
|
Topical term or geographic name as entry element |
Pharmacology. |
9 (RLIN) |
9272 |
|
Topical term or geographic name as entry element |
Therapeutics. |
9 (RLIN) |
9273 |
|
Topical term or geographic name as entry element |
Pharmacy. |
9 (RLIN) |
9274 |
|
Topical term or geographic name as entry element |
Drug Therapy. |
9 (RLIN) |
9275 |
|
Topical term or geographic name as entry element |
Pharmacology, Clinical. |
9 (RLIN) |
9276 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
edited by Walker, Roger |
9 (RLIN) |
9277 |
|
Personal name |
Whittlesea, Cate. |
9 (RLIN) |
134 |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
WorldCat details |
Uniform Resource Identifier |
http://www.worldcat.org/title/clinical-pharmacy-and-therapeutics/oclc/706780869&referer=brief_results |
|
Materials specified |
E-book Fulltext |
Uniform Resource Identifier |
http://lib.ewubd.edu/ebook/7012 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Text |
Koha issues (borrowed), all copies |
12 |
953 ## - Fulltext in GSDL |
Is Fulltext Available in GSDL? |
Not Avaialable |